Purchases and Sales Made in Q4 2023 in Ginkgo Bioworks Holdings, Inc. (DNA)
This table provides information about the institutional ownership of Ginkgo Bioworks Holdings, Inc. (DNA) during Q4 2023. The information is specifically focused on institutions that hold shares of Ginkgo Bioworks Holdings, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-639K- 73.59% |
$805K - $1.14M
|
229K
$2.48M
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-805K- 1.62% |
$1.01M - $1.44M
|
49M
$530M
|
|
|
Feb 09, 2024
Q4 2023
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-1.46M- 82.52% |
$1.84M - $2.61M
|
309K
$3.34M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-2.43M- 46.31% |
$3.06M - $4.35M
|
2.81M
$30.5M
|
|
|
Jan 26, 2024
Q4 2023
|
Baillie Gifford & CO
|
SELL
|
- |
-2.52M- 1.05% |
$3.17M - $4.5M
|
236M
$2.56B
|